Drug profile · INN
lisdexamfetamine dimesylate
LISDEXAMFETAMINE DIMESYLATE
lisdexamfetamine dimesylate (LISDEXAMFETAMINE DIMESYLATE) is a synaptic vesicular amine transporter inhibitor. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Drug details — lisdexamfetamine dimesylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 26
- Data quality
- 0.89
Quick answer
lisdexamfetamine dimesylate (LISDEXAMFETAMINE DIMESYLATE) is a synaptic vesicular amine transporter inhibitor. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Synaptic vesicular amine transporter inhibitor
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
- Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
- Lisdexamfetamine Dimesylate (LDX)
- Lisdexamfetamine dimesylate
- SPD489 (Lisdexamfetamine dimesylate)
- SPD489 (Lisdexamfetamine dimesylate)
- SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
- Vyvanse (lisdexamfetamine dimesylate)
- Lisdexamfetamine
Related & competitor drugs
Frequently asked questions
What is lisdexamfetamine dimesylate?
lisdexamfetamine dimesylate (LISDEXAMFETAMINE DIMESYLATE) is a synaptic vesicular amine transporter inhibitor. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lisdexamfetamine dimesylate?
LISDEXAMFETAMINE DIMESYLATE is a marketed brand name for lisdexamfetamine dimesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lisdexamfetamine dimesylate?
lisdexamfetamine dimesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.